Vera Therapeutics, Inc.

Vera Therapeutics, Inc.verified

VERA

Price:

$42.61

Market Cap:

$2.72B

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartere...[Read more]

Industry

Biotechnology

IPO Date

2021-05-14

Stock Exchange

NASDAQ

Ticker

VERA

The Current Ratio as of December 2025 (TTM) for Vera Therapeutics, Inc. (VERA) is 16.92

According to Vera Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 16.92. This represents a change of -19.47% compared to the average of 21.01 of the last 4 quarters.

Vera Therapeutics, Inc. (VERA) Historical Current Ratio (quarterly & annually)

How has VERA Current Ratio performed in the past?

The mean historical Current Ratio of Vera Therapeutics, Inc. over the last ten years is 12.49. The current 16.92 Current Ratio has changed 13.44% with respect to the historical average. Over the past ten years (40 quarters), VERA's Current Ratio was at its highest in in the March 2024 quarter at 28.05. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

12.49

Median

9.22

Minimum

3.36

Maximum

25.67

Vera Therapeutics, Inc. (VERA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vera Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 570.56%

Maximum Annual Current Ratio = 25.67

Minimum Annual Increase = -54.25%

Minimum Annual Current Ratio = 3.36

Quarterly (TTM)
Annual
YearCurrent RatioChange
202425.67232.79%
20237.7157.09%
20224.91-54.25%
202110.73-52.41%
202022.55570.56%

Vera Therapeutics, Inc. (VERA) Average Current Ratio

How has VERA Current Ratio performed in the past?

The current Current Ratio of Vera Therapeutics, Inc. (VERA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

12.76

5-year avg

14.32

10-year avg

12.49

Vera Therapeutics, Inc. (VERA) Current Ratio vs. Peers

How is VERA’s Current Ratio compared to its peers?

Vera Therapeutics, Inc.’s Current Ratio is less than Celldex Therapeutics, Inc. (19.67), greater than AbCellera Biologics Inc. (10.10), less than Janux Therapeutics, Inc. (35.86), greater than Viridian Therapeutics, Inc. (11.01), greater than Pharvaris N.V. (8.33), greater than Immunome, Inc. (12.13), greater than Biohaven Ltd. (2.86), greater than uniQure N.V. (7.12), greater than Harmony Biosciences Holdings, Inc. (3.75), greater than Nuvation Bio Inc. (8.48),

Build a custom stock screener for Vera Therapeutics, Inc. (VERA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vera Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vera Therapeutics, Inc. (VERA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vera Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Vera Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Vera Therapeutics, Inc. (VERA)?

What is the highest Current Ratio for Vera Therapeutics, Inc. (VERA)?

What is the 3-year average Current Ratio for Vera Therapeutics, Inc. (VERA)?

What is the 5-year average Current Ratio for Vera Therapeutics, Inc. (VERA)?

How does the current Current Ratio for Vera Therapeutics, Inc. (VERA) compare to its historical average?